Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 01, 2019
Source ID
10.1016/j.jhep.2019.01.028

Entities

People

  • Augusto Villanueva
  • Josep M. Llovet
  • Robert Montal

Organizations

  • Cancer Research UK
  • European Commission
  • Generalitat of Catalonia
  • National Cancer Institute
  • Samuel Waxman Cancer Research Foundation
  • United States Department of Defense